IF by specialty › Oncology
Cancer Research — Impact Factor
The 2025 Impact Factor of Cancer Research is 22.6 (Q1 in Oncology; subscription or hybrid).
- Impact Factor
- 22.6 JCR 2025
- JCR category
- Oncology
- Quartile
- Q1 in Oncology
- Publisher
- AACR
- Open access
- subscription or hybrid
- Abbreviations
- Cancer Res
- IF source
- bioxbio.com
Position within the field
Ranked 13 of the 42 journals in Oncology on this site (top 50%).
Oncology journals with a similar Impact Factor
- Lancet Oncology IF 33.7
- Cancer Discovery IF 29.5
- Nature Cancer IF 28.0
- JAMA Oncology IF 23.9
- Journal of Thoracic Oncology IF 23.3
- Journal for ImmunoTherapy of Cancer IF 11.7
About this value
Cancer Research is abbreviated Cancer Res. The Journal Impact Factor of Cancer Research (JCR 2025, released June 2026) is 22.6. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.